Multiplex Molecular Diagnostic Market, Global Outlook and Forecast 2023-2028

Report ID: 1212914 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Multiplex Molecular Diagnostic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Multiplex Molecular Diagnostic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Multiplex Molecular Diagnostic Overall Market Size
    2.1 Global Multiplex Molecular Diagnostic Market Size: 2021 VS 2028
    2.2 Global Multiplex Molecular Diagnostic Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Multiplex Molecular Diagnostic Players in Global Market
    3.2 Top Global Multiplex Molecular Diagnostic Companies Ranked by Revenue
    3.3 Global Multiplex Molecular Diagnostic Revenue by Companies
    3.4 Top 3 and Top 5 Multiplex Molecular Diagnostic Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Multiplex Molecular Diagnostic Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Multiplex Molecular Diagnostic Players in Global Market
        3.6.1 List of Global Tier 1 Multiplex Molecular Diagnostic Companies
        3.6.2 List of Global Tier 2 and Tier 3 Multiplex Molecular Diagnostic Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Multiplex Molecular Diagnostic Market Size Markets, 2021 & 2028
        4.1.2 Real-time PCR
        4.1.3 Nested PCR with Melt Curve Analysis
        4.1.4 PCR with Low density Microarray
        4.1.5 PCR with Liquid Phase Bead Array
        4.1.6 PCR with Electrochemical Detection
    4.2 By Type - Global Multiplex Molecular Diagnostic Revenue & Forecasts
        4.2.1 By Type - Global Multiplex Molecular Diagnostic Revenue, 2017-2022
        4.2.2 By Type - Global Multiplex Molecular Diagnostic Revenue, 2023-2028
        4.2.3 By Type - Global Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Multiplex Molecular Diagnostic Market Size, 2021 & 2028
        5.1.2 Clinical Research Laboratory
        5.1.3 Hospitals
        5.1.4 Academic and Research Centers
        5.1.5 Others
    5.2 By Application - Global Multiplex Molecular Diagnostic Revenue & Forecasts
        5.2.1 By Application - Global Multiplex Molecular Diagnostic Revenue, 2017-2022
        5.2.2 By Application - Global Multiplex Molecular Diagnostic Revenue, 2023-2028
        5.2.3 By Application - Global Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Multiplex Molecular Diagnostic Market Size, 2021 & 2028
    6.2 By Region - Global Multiplex Molecular Diagnostic Revenue & Forecasts
        6.2.1 By Region - Global Multiplex Molecular Diagnostic Revenue, 2017-2022
        6.2.2 By Region - Global Multiplex Molecular Diagnostic Revenue, 2023-2028
        6.2.3 By Region - Global Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Multiplex Molecular Diagnostic Revenue, 2017-2028
        6.3.2 US Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.3.3 Canada Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.3.4 Mexico Multiplex Molecular Diagnostic Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Multiplex Molecular Diagnostic Revenue, 2017-2028
        6.4.2 Germany Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.4.3 France Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.4.4 U.K. Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.4.5 Italy Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.4.6 Russia Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.4.7 Nordic Countries Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.4.8 Benelux Multiplex Molecular Diagnostic Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Multiplex Molecular Diagnostic Revenue, 2017-2028
        6.5.2 China Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.5.3 Japan Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.5.4 South Korea Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.5.5 Southeast Asia Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.5.6 India Multiplex Molecular Diagnostic Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Multiplex Molecular Diagnostic Revenue, 2017-2028
        6.6.2 Brazil Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.6.3 Argentina Multiplex Molecular Diagnostic Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Multiplex Molecular Diagnostic Revenue, 2017-2028
        6.7.2 Turkey Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.7.3 Israel Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.7.4 Saudi Arabia Multiplex Molecular Diagnostic Market Size, 2017-2028
        6.7.5 UAE Multiplex Molecular Diagnostic Market Size, 2017-2028
7 Players Profiles
    7.1 BD
        7.1.1 BD Corporate Summary
        7.1.2 BD Business Overview
        7.1.3 BD Multiplex Molecular Diagnostic Major Product Offerings
        7.1.4 BD Multiplex Molecular Diagnostic Revenue in Global Market (2017-2022)
        7.1.5 BD Key News
    7.2 bioMérieux
        7.2.1 bioMérieux Corporate Summary
        7.2.2 bioMérieux Business Overview
        7.2.3 bioMérieux Multiplex Molecular Diagnostic Major Product Offerings
        7.2.4 bioMérieux Multiplex Molecular Diagnostic Revenue in Global Market (2017-2022)
        7.2.5 bioMérieux Key News
    7.3 SpeeDx
        7.3.1 SpeeDx Corporate Summary
        7.3.2 SpeeDx Business Overview
        7.3.3 SpeeDx Multiplex Molecular Diagnostic Major Product Offerings
        7.3.4 SpeeDx Multiplex Molecular Diagnostic Revenue in Global Market (2017-2022)
        7.3.5 SpeeDx Key News
    7.4 Roche
        7.4.1 Roche Corporate Summary
        7.4.2 Roche Business Overview
        7.4.3 Roche Multiplex Molecular Diagnostic Major Product Offerings
        7.4.4 Roche Multiplex Molecular Diagnostic Revenue in Global Market (2017-2022)
        7.4.5 Roche Key News
    7.5 Contextual Genomics
        7.5.1 Contextual Genomics Corporate Summary
        7.5.2 Contextual Genomics Business Overview
        7.5.3 Contextual Genomics Multiplex Molecular Diagnostic Major Product Offerings
        7.5.4 Contextual Genomics Multiplex Molecular Diagnostic Revenue in Global Market (2017-2022)
        7.5.5 Contextual Genomics Key News
    7.6 GenMark Diagnostics
        7.6.1 GenMark Diagnostics Corporate Summary
        7.6.2 GenMark Diagnostics Business Overview
        7.6.3 GenMark Diagnostics Multiplex Molecular Diagnostic Major Product Offerings
        7.6.4 GenMark Diagnostics Multiplex Molecular Diagnostic Revenue in Global Market (2017-2022)
        7.6.5 GenMark Diagnostics Key News
    7.7 Hologic
        7.7.1 Hologic Corporate Summary
        7.7.2 Hologic Business Overview
        7.7.3 Hologic Multiplex Molecular Diagnostic Major Product Offerings
        7.7.4 Hologic Multiplex Molecular Diagnostic Revenue in Global Market (2017-2022)
        7.7.5 Hologic Key News
    7.8 Luminex Corporation
        7.8.1 Luminex Corporation Corporate Summary
        7.8.2 Luminex Corporation Business Overview
        7.8.3 Luminex Corporation Multiplex Molecular Diagnostic Major Product Offerings
        7.8.4 Luminex Corporation Multiplex Molecular Diagnostic Revenue in Global Market (2017-2022)
        7.8.5 Luminex Corporation Key News
    7.9 Binx Health
        7.9.1 Binx Health Corporate Summary
        7.9.2 Binx Health Business Overview
        7.9.3 Binx Health Multiplex Molecular Diagnostic Major Product Offerings
        7.9.4 Binx Health Multiplex Molecular Diagnostic Revenue in Global Market (2017-2022)
        7.9.5 Binx Health Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Multiplex Molecular Diagnostic Market Opportunities & Trends in Global Market
    Table 2. Multiplex Molecular Diagnostic Market Drivers in Global Market
    Table 3. Multiplex Molecular Diagnostic Market Restraints in Global Market
    Table 4. Key Players of Multiplex Molecular Diagnostic in Global Market
    Table 5. Top Multiplex Molecular Diagnostic Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Multiplex Molecular Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Multiplex Molecular Diagnostic Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Multiplex Molecular Diagnostic Product Type
    Table 9. List of Global Tier 1 Multiplex Molecular Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Multiplex Molecular Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Multiplex Molecular Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Multiplex Molecular Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Multiplex Molecular Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Multiplex Molecular Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Multiplex Molecular Diagnostic Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Multiplex Molecular Diagnostic Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 30. BD Corporate Summary
    Table 31. BD Multiplex Molecular Diagnostic Product Offerings
    Table 32. BD Multiplex Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 33. bioMérieux Corporate Summary
    Table 34. bioMérieux Multiplex Molecular Diagnostic Product Offerings
    Table 35. bioMérieux Multiplex Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 36. SpeeDx Corporate Summary
    Table 37. SpeeDx Multiplex Molecular Diagnostic Product Offerings
    Table 38. SpeeDx Multiplex Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 39. Roche Corporate Summary
    Table 40. Roche Multiplex Molecular Diagnostic Product Offerings
    Table 41. Roche Multiplex Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 42. Contextual Genomics Corporate Summary
    Table 43. Contextual Genomics Multiplex Molecular Diagnostic Product Offerings
    Table 44. Contextual Genomics Multiplex Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 45. GenMark Diagnostics Corporate Summary
    Table 46. GenMark Diagnostics Multiplex Molecular Diagnostic Product Offerings
    Table 47. GenMark Diagnostics Multiplex Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 48. Hologic Corporate Summary
    Table 49. Hologic Multiplex Molecular Diagnostic Product Offerings
    Table 50. Hologic Multiplex Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 51. Luminex Corporation Corporate Summary
    Table 52. Luminex Corporation Multiplex Molecular Diagnostic Product Offerings
    Table 53. Luminex Corporation Multiplex Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 54. Binx Health Corporate Summary
    Table 55. Binx Health Multiplex Molecular Diagnostic Product Offerings
    Table 56. Binx Health Multiplex Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Multiplex Molecular Diagnostic Segment by Type in 2021
    Figure 2. Multiplex Molecular Diagnostic Segment by Application in 2021
    Figure 3. Global Multiplex Molecular Diagnostic Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Multiplex Molecular Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Multiplex Molecular Diagnostic Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Multiplex Molecular Diagnostic Revenue in 2021
    Figure 8. By Type - Global Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
    Figure 12. US Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
    Figure 16. Germany Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 17. France Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
    Figure 24. China Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 28. India Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
    Figure 30. Brazil Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Multiplex Molecular Diagnostic Revenue Market Share, 2017-2028
    Figure 33. Turkey Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Multiplex Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 37. BD Multiplex Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. bioMérieux Multiplex Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. SpeeDx Multiplex Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Roche Multiplex Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Contextual Genomics Multiplex Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. GenMark Diagnostics Multiplex Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Hologic Multiplex Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Luminex Corporation Multiplex Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Binx Health Multiplex Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
60
Frequently Asked Questions
Multiplex Molecular Diagnostic Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Multiplex Molecular Diagnostic Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Multiplex Molecular Diagnostic Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports